New hope for Tough-to-Treat pancreatic cancer
NCT ID NCT04888312
Summary
This study is testing the safety and effectiveness of a new drug called mitazalimab when given alongside standard chemotherapy to people with advanced pancreatic cancer that has spread. The goal is to see if this combination can better control the cancer and help patients live longer. The trial will involve about 94 adults who have not yet received chemotherapy for their metastatic pancreatic cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier Universitaire de Bordeaux - Hôpital Haut-Lévêque,
Bordeaux, France
-
Centre Lyon Berard
Lyon, France
-
Cliniques Universitaires St-Luc
Brussels, Belgium
-
Hopital Européen Georges Pompidou
Paris, 75015, France
-
Hospital Erasme
Brussels, Belgium
-
Hospital Universitario La Paz, Madrid, Spain
Madrid, Spain
-
Hospital Universitario Miguel Servet, Zaragoza, Spain
Zaragoza, Spain
-
Hospital Universitario Ramon y Cajal, Madrid, Spain
Madrid, Spain
-
Hospital Universitario Vall d'Hebron, Barcelona, Spain
Barcelona, Spain
-
Hospital Universitario Virgen del Rocio, Sevilla, Spain
Seville, Spain
-
Institut Paoli-Calmettes
Marseille, France
-
Institute de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, France
-
UZA Antwerp
Edegem, Belgium
-
Universitair Ziekenhuis Gent
Ghent, 9000, Belgium
Conditions
Explore the condition pages connected to this study.